復星醫藥(02196.HK)控股股東提前終止股份減持 並承諾一年內不減持
復星醫藥(02196.HK)(600196.SH)公佈,公司控股股東復星高科技決定於昨日(24日)提前終止股份減持計劃,並承諾自昨日起的一年內不減持公司股份。
根據今年9月2日的減持計劃通知,復星高科技計劃減持不超過公司總股本3%的A股,其中以集中競價方式減持不超過公司總股本1%的A股、以大宗交易方式減持不超過公司總股本2%的A股。
自今年9月14日至9月30日,於減持計劃下復星高科技累計減持公司3,910.7萬股A股,約佔公司總股本的1.46%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.